Publications

As of October 2021, I have published >400 original articles and new concept papers, among which I am the first, last or co-last author in about 50% of papers.  A number of papers have been published in high-impact journals with Impact Factor >10 (New England Journal of Medicine, Nature, Nature Genetics, Nature Reviews Clinical Oncology, JAMA, JAMA Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute, Gastroenterology, Gut, Science Translational Medicine, American Journal of Gastroenterology, etc.).  (Impact Factor is used merely for convenience.  I do not intend to use it as a definitive metric of quality of any given journal.)

I have published over 30 other peer-reviewed articles, many of which have introduced novel concepts, paradigms, theories, and research frameworks related to MPE (listed below).

Publications at Pubmed (this misses 6 papers with only my first initial; S Ogino as my name), including Ann Oncol, Brit J Cancer, Gut, J Pathol, and Histopathology).
http://www.ncbi.nlm.nih.gov/pubmed/?term=ogino+shuji

Citation records at Google Scholars (over 48,700 citations and h-index of 112 as of November 2021)
http://scholar.google.com/citations?user=87TPyfoAAAAJ&hl=en

Publications at Pubmed Central (full text freely available):
http://www.ncbi.nlm.nih.gov/pmc/?term=ogino+shuji

Clarivate Analytics / Web of Science (formerly, Thomson Reuters) has determined me as one of the “Most Influential Scientific Minds: 2014” and one of the “Highly Cited Researchers” in 2015,  2016, 2017, 2018, 2019, 2020, 2021. http://highlycited.com/#ogino

I was among the 17 names at Harvard T.H. Chan School of Public Health https://www.hsph.harvard.edu/news/features/eighteen-hsph-faculty-are-among-the-most-cited-in-their-fields/.

 

Selected original papers

Chan AT, Ogino S, Fuchs CS.  Aspirin use and risk of colorectal cancer according to cyclooxygenase-2 expression.  N Engl J Med 2007;356:2131-42.

Chan AT, Ogino S, Fuchs CS.  Aspirin use and survival after diagnosis of colorectal cancer.  JAMA 2009;302:649-658.

Morikawa T, Kuchiba A, Yamauchi M, Meyerhardt JA, Shima K, Nosho K, Chan AT, Giovannucci E, Fuchs CS, Ogino S.  Association of CTNNB1 (β-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.  JAMA 2011;305:1685-1694. PMCID:PMC3087286109

Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs CS, Ogino S.  Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.  Gut 2012;61:847-854. PMCID:PMC3345105

Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR.  Tumor microenvironment contributes to innate RAF-inhibitor resistance through HGF secretion.  Nature 2012;487:500-504. PMCID:PMC3711467

Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S.  Aspirin use, tumor PIK3CA mutation status, and colorectal-cancer survival.  N Engl J Med 2012;367:1596-1606. PMCID:PMC3532946

Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, Kuo CJ, Camargo FD.  Restriction of intestinal stem cell expansion and the regenerative response by YAP.  Nature 2013;493:106-110. PMCID:PMC3536889

Nishihara R, Lochhead P, Kuchiba A, Jung S, Yamauchi M, Liao X, Imamura Y, Qian ZR, Morikawa T, Wang M, Spiegelman D, Cho E, Giovannucci E, Fuchs CS, Chan AT, Ogino S.  Aspirin use and risk of colorectal cancer according to BRAF mutation status.  JAMA 2013;309:2563-2571.  PMCID:PMC3743040

Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, Inamura K, Kim SA, Kuchiba A, Yamauchi M, Imamura Y, Willett WC, Rosner BA, Fuchs CS, Giovannucci E, Ogino S*, Chan AT*.  Long-term colorectal cancer incidence and mortality after lower endoscopy.  N Engl J Med 2013;369:1095-1105. (* Co-last authors) PMCID:PMC3840160

Lochhead P, Kuchiba A, Imamura Y, Liao X, Yamauchi M, Nishihara R, Qian ZR, Morikawa T, Shen J, Meyerhardt JA, Fuchs CS, Ogino S.  Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.  J Natl Cancer Inst 2013;105:1151-1156.  (Because of this paper, I have been an advisor for Lower GI Panel of AJCC).

Fink SP, Yamauchi M, Nishihara R, Jung S, Kuchiba A, Wu K, Cho E, Giovannucci E, Fuchs CS*, Ogino S*, Markowitz SD*, Chan AT*.  Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).  Sci Transl Med 2014;6:233re2.  (* Co-last authors) PMCID:PMC4030641

Inamura K, Yamauchi M, Nishihara R, Lochhead P, Qian ZR, Kuchiba A, Kim SA, Mima K, Sukawa Y, Jung S, Zhang X, Wu K, Cho E, Chan AT, Meyerhardt JA, Harris CC, Fuchs CS, Ogino S.  Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.  J Natl Cancer Inst 2014;106:dju195.  PMCID:PMC4161997

Giannakis M, Hodis E, Mu J, Yamauchi M, Rosenbluh J, Cibulskis K, Saksena G, Lawrence MS, Qian ZR, Nishihara R, Van Allen EM, Hahn WC, Gabriel SB, Lander ES, Getz G, Ogino S, Fuchs CS, Garraway LA.  RNF43 is frequently mutated in colorectal and endometrial cancers.  Nat Genet 2014;46:1264-1266.
http://www.dana-farber.org/Newsroom/News-Releases/Unsuspected-gene-found-frequently-mutated-in-colorectal-endometrial-cancers.aspx

Song M, Nishihara R, Wu K, Qian ZR, Kim SA, Sukawa Y, Mima K, Inamura K, Masuda A, Yang J, Fuchs CS, Giovannucci EL, Ogino S,* Chan AT.  Marine ω-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability.  J Natl Cancer Inst 2015.  (* Co-last and co-corresponding author)

Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, Bullman S, Milner DA, Harris CC, Giovannucci E, Garraway LA, Freeman GJ, Dranoff G, Chan AT, Garrett WS, Huttenhower C, Fuchs CS, Ogino S. Fusobacterium nucleatum and T-cells in colorectal carcinoma. JAMA Oncol 2015;1:653-661.

Tu HC, Schwitalla S, Qian Z, LaPier GS, Yermalovich A, Ku YC, Chen SC, Viswanathan SR, Zhu H, Nishihara R, Inamura K, Kim SA, Morikawa T, Mima K, Sukawa Y, Yang J, Meredith G, Fuchs CS, Ogino S, Daley GQ. LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans.  Gene Dev 2015;29:1074-1086.

Song M, Nishihara R, Wang M, Chan AT, Qian ZR, Inamura K, Zhang X, Ng K, Kim SA, Mima K, Sukawa Y, Nosho K, Fuchs CS, Giovannucci EL, Wu K, Ogino S.  Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.  Gut 2016.

Inamura K, Song M, Jung S, Nishihara R, Yamauchi M, Lochhead P, Qian ZR, Kim SA, Mima K, Sukawa Y, Masuda A, Imamura Y, Zhang X, Pollak MN, Mantzoros CS, Harris CC, Giovannucci E, Fuchs CS, Cho E, Chan AT, Wu K, Ogino S. Prediagnosis plasma adiponectin in relation to colorectal cancer risk according to KRAS mutation status.  J Natl Cancer Inst 2016;108(4). pii: djv363.

Cao Y, Nishihara R, Wu K, Wang M, Ogino S, Willett WC, Spiegelman D, Fuchs CS, Giovannucci EL, Chan AT.  Population-wide impact of long-term use of aspirin and the risk for Cancer.       JAMA Oncol 2016;2:762-769.

Mima K, Nishihara R, Yang J, Dou R, Masugi Y, Shi Y, da Silva A, Cao Y, Song M, Nowak JA, Gu M, Li W, Morikawa T, Zhang X, Wu K, Baba H, Giovannucci EL, Meyerhardt JA, Chan AT, Fuchs CS, Qian ZR, Ogino S. MicroRNA MIR21 (miR-21) and PTGS2 expression in colorectal cancer and patient survival.  Clin Cancer Res 2016;22:3841-3848.

Song M, Nishihara R, Cao Y, Chun E, Qian ZR, Mima K, Inamura K, Masugi Y, Nowak JA, Nosho K, Wu K, Wang M, Giovannucci E, Garrett WS, Fuchs CS, Ogino S,* Chan AT. Marine ω-3 polyunsaturated fatty acid intake and risk of colorectal cancer according to tumor-infiltrating T cells.  JAMA Oncol 2016;2:1197-1206. (* co-last and co-corresponding author)

Yang S, Imamura Y, Jenkins R, Cañadas I, Kitajima S, Aref AR, Brannon AL, Oki E, Castoreno A, Zhu Z, Thai TC, Reibel J, Qian Z, Ogino S, Wong KK, Baba H, Kimmelman AC, Pasca di Magliano M, Barbie DA. Autophagy inhibition dysregulates TBK1 signaling and promotes pancreatic inflammation.  Cancer Immunol Res 2016;4:520-530.

Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, Sukawa Y, Stewart C, Rosenberg M, Mima K, Inamura K, Nosho K, Nowak JA, Lawrence MS, Giovannucci EL, Chan AT, Ng K, Meyerhardt JA, Van Allen EM, Getz G, Gabriel SB, Lander ES, Wu CJ, Fuchs CS, Ogino S,* Garraway LA. Genomic correlates of immune cell infiltrates in colorectal carcinoma.  Cell Rep 2016;15:857-865.  (Additional information in 2016;17:1206) (* Co-last and co-corresponding author)

Mei Z, Cui L, Li C, Ogino S. Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.  Ann Oncol 2016;27:1836-1848.

Esfahani SA, Heidari P, Kim SA, Ogino S, Mahmood U. Optical imaging of mesenchymal epithelial transition factor (MET) for enhanced detection and characterization of primary and metastatic hepatic tumors.  Theranostics 2016;6:2028-2038.

Cao Y, Nishihara R, Qian ZR, Song M,  Mima K, Inamura K, Nowak JA, Drew DA, Lochhead P, Nosho K, Morikawa T, Zhang X, Wu K, Wang M, Garrett WS, Giovannucci EL, Fuchs CS, Chan AT, Ogino S. Regular aspirin use associates with lower risk of colorectal cancers with low numbers of tumor-infiltrating lymphocytes.  Gastroenterology 2016;151:879-892.e4.

Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song M, da Silva A,Gu M, Li W, Hamada T, Kosumi K, Hanyuda A, Liu L, Kostic AD, Giannakis M, Bullman S, Brennan CA, Milner DA, Baba H, Garraway LA, Meyerhardt JA, Garrett WS, Huttenhower C, Meyerson M, Giovannucci EL, Fuchs CS, Nishihara R, Ogino SFusobacterium nucleatum in colorectal carcinoma tissue according to tumor location.  Clin Transl Gastroenterol 2016;7:e200.

Dou R, Nishihara R, Cao Y, Hamada T, Mima K, Masuda A, Masugi Y, Shi Y, Gu M, Li W, da Silva A, Nosho K, Zhang X, Meyerhardt JA, Giovannucci EL, Chan AT, Fuchs CS, Qian ZR, Ogino S. MicroRNA let-7, T cells, and patient survival in colorectal cancer.  Cancer Immunol Res 2016;4:927-935.

Song M, Zhong X, Meyerhardt JA, Giovannucci EL, Ogino S, Fuchs CS, Chan AT. Marine omega-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis.  Gut 2016.

Masugi Y, Nishihara R, Yang J, Mima K, da Silva A, Shi Y, Inamura K, Cao Y, Song M, Nowak JA, Liao X, Nosho K, Chan AT, Giannakis M, Bass AJ, Hodi FS, Freeman GJ, Rodig S, Fuchs CS, Qian ZR, Ogino S. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.  Gut 2017.

 

 

Papers on MPE, disciplinarity, concepts, paradigms, theories, principles, and research frameworks / models

Ogino S, Stampfer M.  Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology [editorial].  J Natl Cancer Inst 2010;102:365-367.

Ogino S, Chan AT, Fuchs CS, Giovannucci E.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field [review].  Gut 2011;60:397-411.

Ogino S, Galon J, Fuchs CS, Dranoff G.  Cancer immunology – integrated analysis of host and tumor factors for personalized medicine [review].  Nat Rev Clin Oncol 2011:8:711-719.

Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, Giovannucci E, Fuchs CS, Ogino S.  Colorectal cancer: a tale of two sides or a continuum? [review – leading article]  Gut 2012;61:794-797.

Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E.  Interdisciplinary education to integrate pathology and epidemiology: Towards molecular and population-level health science [special article].  Am J Epidemiol 2012;176:659-667.

Ogino S, Giovannucci E.  Lifestyle factors and colorectal cancer microsatellite instability – Molecular pathological epidemiology science, based on unique tumour principle [invited commentary].  Int J Epidemiol 2012;41:1072-1074.

Ogino S, Beck AH, King EE, Sherman ME, Milner DA, Giovannucci E.  Ogino et al. respond to “The 21st century epidemiologist” [reply to invited commentary].  Am J Epidemiol 2012;176:672-674.

Ogino S, Fuchs CS, Giovannucci E.  How many molecular subtypes?  Implications of the unique tumor principle in personalized medicine [review].  Expert Rev Mol Diagn 2012;12:621-628.

Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt AJ, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E.  Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease [review].  Mod Pathol 2013;26:465-484.

Fuchs CS, Ogino S.  Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex! [“Understanding The Pathway” article]  J Clin Oncol 2013;31:4358-4361.

Field AE, Camargo Jr CA, Ogino S.  The merits of subtyping obesity: one size does not fit all [viewpoint].  JAMA 2013;310:2147-2148.

Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology [review].  Oncogene 2014;33:2949-2955.

Lochhead P, Chan AT, Giovannucci E, Fuchs CS, Wu K, Nishihara R, O’Brien M, Ogino S.  Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions [review].  Am J Gastroenterol 2014.

Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, Ogino S.  Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression [review].  Mod Pathol 2015.

Nishi A, Kawachi I, Koenen KC, Wu K, Nishihara R, Ogino S.  Lifecourse epidemiology and molecular pathological epidemiology.  Am J Prev Med 2015.

Wang M, Kuchiba A, Ogino S.  Am J Epidemiol 2015. (new method in MPE to deal with multiple subtyping biomarkers)

Nishihara R, VanderWeele TJ, Shibuya K, Mittleman MA, Wang M, Field AE, Giovannucci E, Lochhead P, Ogino S.  Molecular pathological epidemiology gives clues to paradoxical findings.  Eur J Epidemiol 2015.  (This paper unites MPE and the causal inference area).

Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan AT, Poole EM, Tamimi R, Tworoger SS, Giovannucci E, Rosner B, Ogino S. Statistical methods for studying disease subtype heterogeneity. Stat Med 2016;35:782-800.  (We developed and compiled methods of examining subtype heterogeneity in various settings of MPE research.)

Ogino S, Nishihara R, VanderWeele TJ, Wang M, Nishi A, Lochhead P, Qian ZR, Zhang X, Wu K, Nan H, Yoshida K, Milner DA, Chan AT, Field AE, Camargo CA, Williams MA, Giovannucci EL. The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine.  Epidemiology 2016;27:602-611.  (This paper introduced the disease continuum theory, and relevance and applicability of the MPE paradigm to all diseases.  In addition, this paper introduced the integrative fields of “pharmaco-MPE” and “immuno-MPE”.)

Nishi A, Milner DA, Giovannucci EL, Nishihara R, Tan AS, Kawachi I, Ogino S. Integration of molecular pathology, epidemiology, and social science for global precision medicine.  Expert Rev Mol Diagn 2016;16:11-23.  (This introduced the new field of “social MPE”.)

Hamada T, Keum N, Nishihara R, Ogino S.  Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.  J Gastroenterol 2017.  (This paper introduced the integrative field of “microbial MPE”.)

Ogino S, et al. Gut 2018.  “Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine” (This paper introduced the integrative field of immunology-MPE (immuno-MPE).

Ogino S, Giannakis M. Lancet 2018.  “Immunoscore for (colorectal) cancer precision medicine”.

Ogino S et al. Annu Rev Pathol 2019.

Akimoto N et al. Nat Rev Clin Oncol 2021.

 

Proceedings of major conferences / symposia related to MPE

Kuller LH, Bracken MB, Ogino S, Prentice RL, Tracy RP. The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium.  Am J Epidemiol 2013;178:1350-1354.

Ogino S.  Molecular pathological epidemiology (MPE): Overview of its paradigm and wide applicability even without tumor tissue. In: Proceedings of the Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2013 Oct 27-30; National Harbor, MD.  Can Prev Res 2013;6(11 Suppl):CN06-01.

Epplein M, et al.  Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups report.  Cancer Epidemiol Biomarkers Prev 2014.

Ogino S, Campbell PT, Nishihara R, Phipps AI, Beck AH, Sherman ME, Chan AT, Troester MA, Bass AJ, Fitzgerald KC, Irizarry RA, Kelsey KT, Nan H, Peters U, Poole EM, Qian ZR, Tamimi RM, Tchetgen Tchetgen EJ, Tworoger SS, Zhang X, Giovannucci EL, van den Brandt PA, Rosner BA, Wang M, Chatterjee N, Begg CB.  Proceedings of The Second International Molecular Pathological Epidemiology (MPE) Meeting.  Cancer Causes Cont 2015.

Campbell PT, Rebbeck TR, Nishihara R, Beck AH, Begg CB, Bogdanov AA, Cao Y, Coleman HG, Freeman GJ, Heng YJ, Huttenhower C, Irizarry RA, Kip NS, Michor F, Nevo D, Peters U, Phipps AI, Poole EM, Qian ZR, Quackenbush J, Robins H, Rogan PK, Slattery ML, Smith-Warner SA, Song M, VanderWeele TJ, Xia D, Zabor EC, Zhang X, Wang M, Ogino S. Proceedings of the Third International Molecular Pathological Epidemiology (MPE) Meeting.  Cancer Causes Cont 2017.